GIORDANO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 37.482
EU - Europa 28.455
AS - Asia 4.393
OC - Oceania 81
Continente sconosciuto - Info sul continente non disponibili 38
SA - Sud America 32
AF - Africa 17
Totale 70.498
Nazione #
US - Stati Uniti d'America 37.391
GB - Regno Unito 11.340
IE - Irlanda 4.905
CN - Cina 3.415
UA - Ucraina 3.238
FR - Francia 1.807
SE - Svezia 1.787
DE - Germania 1.701
IT - Italia 1.480
RU - Federazione Russa 1.033
FI - Finlandia 742
SG - Singapore 355
IN - India 210
VN - Vietnam 177
TR - Turchia 101
CA - Canada 81
BE - Belgio 74
AU - Australia 66
ES - Italia 58
NL - Olanda 54
EU - Europa 36
IM - Isola di Man 27
JP - Giappone 25
AT - Austria 24
PL - Polonia 23
CZ - Repubblica Ceca 22
GR - Grecia 22
HU - Ungheria 20
NZ - Nuova Zelanda 15
RO - Romania 15
HK - Hong Kong 14
BR - Brasile 13
EE - Estonia 12
CY - Cipro 11
IL - Israele 11
CL - Cile 10
DK - Danimarca 9
KR - Corea 9
SA - Arabia Saudita 8
BG - Bulgaria 7
CH - Svizzera 7
RS - Serbia 7
EG - Egitto 6
ID - Indonesia 6
IR - Iran 6
TW - Taiwan 6
AL - Albania 5
HR - Croazia 5
AR - Argentina 4
BD - Bangladesh 4
LT - Lituania 4
LV - Lettonia 4
MA - Marocco 4
MX - Messico 4
PA - Panama 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
IQ - Iraq 3
MY - Malesia 3
PK - Pakistan 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
EC - Ecuador 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MD - Moldavia 2
ME - Montenegro 2
MK - Macedonia 2
MN - Mongolia 2
OM - Oman 2
PH - Filippine 2
TN - Tunisia 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GE - Georgia 1
GH - Ghana 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MC - Monaco 1
MS - Montserrat 1
MT - Malta 1
PE - Perù 1
SI - Slovenia 1
TH - Thailandia 1
Totale 70.498
Città #
Southend 10.616
Fairfield 6.225
Dublin 4.863
Woodbridge 2.914
Chandler 2.786
Jacksonville 2.694
Ashburn 2.604
Wilmington 2.433
Houston 2.427
Seattle 2.300
Cambridge 2.056
Menlo Park 2.031
Ann Arbor 1.345
Princeton 1.340
Nanjing 934
Siena 619
Beijing 608
San Mateo 516
Boardman 439
San Diego 359
Nanchang 351
Shenyang 220
Singapore 216
Helsinki 214
Düsseldorf 209
Moscow 204
Tianjin 176
Dong Ket 175
Hebei 162
New York 155
Delhi 147
Kunming 143
Changsha 132
London 127
Norwalk 118
Jiaxing 117
Shanghai 97
Dearborn 90
Florence 89
San Francisco 87
Falls Church 79
Izmir 77
Venezia 76
Brussels 74
Hangzhou 67
Jinan 65
Toronto 65
Milan 55
Rome 52
Zhengzhou 50
Málaga 47
Ningbo 47
Lancaster 45
Tappahannock 43
Fremont 42
Taizhou 36
Chicago 34
Washington 34
Lanzhou 32
Mestre 32
Changchun 31
Frankfurt am Main 30
Redwood City 30
Melbourne 28
Paris 28
Amsterdam 27
Fort Worth 27
Kilburn 27
Prescot 27
Edinburgh 26
Hounslow 26
Philadelphia 25
Vienna 24
Douglas 23
Guangzhou 23
Canberra 20
Los Angeles 20
Phoenix 20
Sezze 20
Fuzhou 19
Lappeenranta 19
Budapest 17
Chiswick 17
Dallas 16
Scottsdale 16
Brno 15
Hefei 13
Groningen 12
Tallinn 12
Tokyo 12
Islington 11
Munich 11
Padova 11
Auburn Hills 10
Auckland 10
Cagliari 10
Falkenstein 10
Pozza 10
Sydney 10
Berlin 9
Totale 55.142
Nome #
Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. 378
PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells 255
Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment 248
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 241
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 234
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. 219
Depletion of the RNA binding protein HNRNPD impairs homologous recombination by inhibiting DNA-end resection and inducing R-loop accumulation 216
The zebrafish as a model for nociception studies. 213
New players in ovarian cancer. 209
Effect of rMnSOD on Sodium Reabsorption in Renal Proximal Tubule in Ochratoxin A—Treated Rats 199
NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer 198
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 194
Study of viral integration of HPV-16 in young patients with LSIL 193
An Intrinsically Disordered Region of the Acetyltransferase p300 with Similarity to Prion-Like Domains Plays a Role in Aggregation 193
Triple negative breast cancer: Looking for the missing link between biology and treatments 193
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells 192
Zebrafish Tmem230a cooperates with the Delta/Notch signaling pathway to modulate endothelial cell number in angiogenic vessels 191
Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats 190
Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma 186
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 186
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 185
Uric Acid Amplifies Aβ Amyloid Effects Involved in the Cognitive Dysfunction/Dementia: Evidences From an Experimental Model In Vitro 183
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino 183
SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment 182
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. 181
Dissecting Pin1 and phospho-pRb regulation 181
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? 179
Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs 178
Virtual Reality in Health System: Beyond Entertainment. A Mini-Review on the Efficacy of VR During Cancer Treatment 176
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 176
Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects? 175
Translational Research and Plasma Proteomic in Cancer 173
Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy 172
The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records. 172
"A method of inhibiting cancer cell growth using a vector expressing pRb2/p130." 172
Gastroprotective effects of L-Lysine salification of ketoprofen in ethanol-injured gastric mucosa 172
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 170
A case of human polyomavirus Bk infection in a patient affected by late stage prostate cancer: could viral infection be correlated with cancer progression? 168
Overexpression and Nucleolar Localization of γ-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma 168
NSP 5a3a's link to nuclear-cyto proteins B23 and hnRNP-L between normal and aberrant breast cell lines. 167
The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression 167
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 167
Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia 167
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells 167
Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins 166
Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer 165
”Tumor Suppressor Protein pRB2, related gene products, and DNA encoding therefor” 164
NONO regulates the intra-S-phase checkpoint in response to UV radiation 163
Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt`s lymphoma cell lines 163
12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells 163
2,3,7,8-Tetrachlorodibenzo-p-dioxin modifies expression and nuclear/cytosolic localization of bovine herpesvirus 1 immediate-early protein (bICP0) during infection. 163
A study of quiet eye's phenomenon in the shooting section of "laser run" of modern pentathlon 163
null 162
Dysregulated calcium homeostasis and oxidative stress in chronic myeloid leukemia (CML) cells. 162
Multifaceted Breast Cancer: The Molecular Connection With Obesity 161
A functional biological network centered on XRCC3: A new possible marker of chemoradiotherapy resistance in rectal cancer patients 161
Novel insights in basic and applied stem cell therapy 160
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy 160
Are RB proteins a potential substrate of Pin1 in the regulation of the cell cycle? 158
Pin1 and nuclear receptors: A new language? 158
Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines 158
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer 157
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives 156
" Methods of inhibiting smooth muscle cell proliferation and preventing restenosis with a vector expressing RB2/p130 " 155
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: A combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors 155
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells 154
pRb2/p130 gene overexpression induces astrocyte differentiation 153
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer 153
The PPARβ/δ Agonist GW0742 Induces Early Neuronal Maturation of Cortical Post-Mitotic Neurons: Role of PPARβ/δ in Neuronal Maturation 153
CyclinD1 Down-Regulation and Increased Apoptosis Are Common Features of Cohesinopathies 153
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 153
null 153
Cdk9-55: a new player in muscle regeneration 152
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease. 152
Prevention of Nephrotoxicity Induced by Cyclosporine-A: Role of Antioxidants 152
The tumor suppressor role of CTCF 151
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 151
Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature? 150
null 150
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer 149
Blood-derived stem cells (BDSCs) plasticity: In vitro hepatic differentiation. 149
Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells 149
Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells 148
Anticancer therapeutic strategies based on CDK inhibitors. 148
Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development 148
CDK9 (PITALRE): a multifunctional cdc2-related kinase 148
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 148
”Tumor Suppressor Protein pRB2, related gene products, and DNA encoding therefor” 147
Conservative treatment of early endometrial cancer 147
null 147
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 146
Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes 146
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 146
null 146
Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors 145
Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model 145
The Protective Effect of Apocynin on Cyclosporine A-Induced Hypertension and Nephrotoxicity in Rats 145
Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy 145
Frequent loss of pRb2/p130 in human ovarian carcinoma 144
The role of the Cdk9/Cyclin T1 complex in T cell differentiation 144
Totale 17.092
Categoria #
all - tutte 242.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 242.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013.229 0 545 1.282 2.408 1.007 1.120 1.277 1.925 1.283 1.195 303 884
2020/202112.337 453 1.340 379 1.187 436 1.272 531 1.868 1.938 1.099 981 853
2021/20229.037 657 1.046 696 482 523 366 605 349 606 1.022 735 1.950
2022/202310.804 824 445 1.212 1.750 1.144 2.648 122 868 1.040 143 403 205
2023/20245.759 330 166 468 147 196 1.672 2.127 111 33 110 38 361
2024/20251.140 369 771 0 0 0 0 0 0 0 0 0 0
Totale 71.510